Related Experiment Video
Updated: May 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Dyslipidemia management
Insights
Statins effectively reduce stroke risk in patients with coronary artery disease and recent cerebrovascular events. Current guidelines recommend statin therapy for stroke or TIA prevention.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Lipid-lowering therapies, particularly statins, have been extensively studied for vascular event reduction over the past decade.
- These advancements have significantly influenced strategies for stroke prevention.
Purpose of the Study:
- To review the impact of statins and other lipid therapies on vascular events.
- To evaluate the role of these therapies in stroke prevention.
Main Methods:
- Analysis of numerous studies evaluating statins and lipid therapies.
- Review of clinical guidelines and recent findings on stroke prevention.
Main Results:
- Statins demonstrate a significant reduction in stroke rates for patients with established coronary artery disease.
- High-dose statin therapy is effective in preventing stroke in individuals with recent cerebrovascular events, even without heart disease.
- Clinical guidelines now recommend statin initiation for patients experiencing stroke or transient ischemic attack (TIA).
Conclusions:
- The majority of patients with stroke or TIA should receive statin treatment.
- Multimodal medical therapy is now a cornerstone of established stroke prevention strategies.
Purpose Of Review:
: Numerous studies have been conducted in the past decade evaluating the use of statins and other lipid therapies for reducing vascular events. These studies have impacted the area of stroke prevention.
Recent Findings:
: For patients with established coronary artery disease, statins reduce the rate of stroke. High-dose statin treatment has also been found to reduce the rate of stroke in patients with recent cerebrovascular events and no evidence of heart disease. As a result, initiation of statin therapy for patients with stroke or TIA is now recommended in clinical guidelines. Whether agents that modulate high-density lipoprotein cholesterol are effective in reducing stroke is still the subject of clinical study.
Summary:
: Most patients with stroke or TIA should be treated with statins. The era of multimodal medical therapy for stroke prevention is now well established.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis IV: Nursing Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...